Treatment of Resistant Atrial Fibrillation
Authors:
- Dawn G. ZarembskiDZDawn G. Zarembski
- Paul E. NolanPNPaul E. Nolan
- Marion K. SlackMSMarion K. Slack
- Anthony C. CarusoACAnthony C. Caruso
- 25 September 1995
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 155 (17) , 1885-1891
Abstract
Research from JAMA Internal Medicine — Treatment of Resistant Atrial Fibrillation — A Meta-analysis Comparing Amiodarone and FlecainideKeywords
This publication has 21 references indexed in Scilit:
- Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillationThe American Journal of Cardiology, 1993
- Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillationJACC, 1992
- Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.Circulation, 1991
- Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.Circulation, 1990
- Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation, 1990
- Preliminary Report of the Stroke Prevention in Atrial Fibrillation StudyNew England Journal of Medicine, 1990
- Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutterThe American Journal of Cardiology, 1989
- Therapeutic efficacy and safety of oral propafenone for atrial fibrillationThe American Journal of Cardiology, 1989
- Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atriumThe American Journal of Cardiology, 1987
- Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study.Heart, 1971